8/15/2019 PQLI Application of Science- And Risk-based Approaches

1/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

2/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

3/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

4/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

5/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

6/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

7/20

http://c.j.potter@btinternet.com/http://c.j.potter@btinternet.com/

8/15/2019 PQLI Application of Science- And Risk-based Approaches

8/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

9/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

10/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

11/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

12/20

http://Cookg1@wyeth.com/

8/15/2019 PQLI Application of Science- And Risk-based Approaches

13/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

14/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

15/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

16/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

17/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

18/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

19/20

8/15/2019 PQLI Application of Science- And Risk-based Approaches

20/20

http://ec.europa.eu/enterprise/pharmaceuticals/varreg/index.htmhttp://ec.europa.eu/enterprise/pharmaceuticals/varreg/index.htmhttp://Rob.Hughes@astrazeneca.com/